Details for 2016750495

Up to date per 02.04.2026

Actions

Title / Product Name

GEMEINSAME VERWENDUNG VON ANTI PD-1 UND ANTI M-CSF-ANTIKÖRPER IN DER BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016750495

EP Publication Number

3328425

E-Number

1423727

Language

PCT Number

IB16054487

Publication Date

06.06.2018 A

25.08.2021 B1

Registration Date

25.08.2021

AT Publication Date

15.09.2021

Application Date

27.07.2016

Registration Number

Priorities

29.07.2015

201562198384 P

21.06.2016

201662352637 P

IPC

C07K 16/28 20060101AFI20200710BHEP

Maximum Duration of Protection

27.07.2036

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

FJAELLSKOG, Marie-Louisec/o Novartis Institutes for BioMedical Research Inc. 220 Massachusetts Avenue Cambridge, Massachusetts 02139US

CAMERON, Johnc/o Novartis Institutes for BioMedical Research Inc. 220 Massachusetts Avenue Cambridge, Massachusetts 02139US

CAO, Zhuc/o Novartis Institutes for BioMedical Research Inc. 220 Massachusetts Avenue Cambridge, Massachusetts 02139US

CIPOLLETTA, Danielac/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

MACISAAC, Kenziec/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US